ABIONIC
Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergy profiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection. Abionic ... SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements. Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab. Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland. Abionic appreciates the support it has received from:
ABIONIC
Industry:
Biotechnology Health Care Life Science Medical Nanotechnology Pharmaceutical
Founded:
2010-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.abionic.com
Total Employee:
51+
Status:
Active
Contact:
(412) 169-3825
Total Funding:
26.53 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Google Tag Manager Content Delivery Network Domain Not Resolving Apache Microsoft Exchange Online Office 365 Mail
Current Employees Featured
Nicolas Durand CEO and Founder @ Abionic
CEO and Founder
2009-10-01
Iwan Märki CTO @ Abionic
CTO
2010-08-01
Boris Iseli CFO @ Abionic
CFO
2014-10-01
Fabien Rebeaud CSO @ Abionic
CSO
2016-07-01
Nelson Dumas US Business Development Director @ Abionic
US Business Development Director
Founder
Investors List
Pierangelo Bottinelli
Pierangelo Bottinelli investment in Series C - Abionic
Jean- Bernard
Jean- Bernard investment in Series C - Abionic
Arkady Volozh
Arkady Volozh investment in Series C - Abionic
Peter Letmathe
Peter Letmathe investment in Series C - Abionic
Philippe Glatz
Philippe Glatz investment in Series C - Abionic
Verve Ventures
Verve Ventures investment in Series C - Abionic
Nelson Dumas
Nelson Dumas investment in Series C - Abionic
3wVentures
3wVentures investment in Series C - Abionic
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series C - Abionic
MedHoldings
MedHoldings investment in Series B - Abionic
Official Site Inspections
http://www.abionic.com Semrush global rank: 9.81 M Semrush visits lastest month: 102
- Host name: h2web75.infomaniak.ch
- IP address: 83.166.138.21
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Abionic"
Home | Abionic
The winner of multiple industry awards, including "Swiss MedTech of the year" in 2023, Abionic is a Swiss MedTech company spun-out of EPFL in 2010 on a vision nanofluidics could transform …See details»
Abionic - Wikipedia
Abionic SA is a company specialized in the development of ultra-rapid in vitro diagnostic tests, located in Lausanne, Switzerland. Abionic has developed the abioSCOPE, a point-of-care diagnostic platform using its patented nanofluidic technology. The abioSCOPE is implemented in intensive care units and emergency departments to enable early identification …See details»
Abionic - Crunchbase Company Profile & Funding
Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies …See details»
Abionic - 2025 Company Profile, Funding & Competitors - Tracxn
Abionic is a series C company based in Epalinges (Switzerland), founded in 2010 by Nicolas Durand. It operates as a Provider of point-of-care diagnostic tool for allergy profiles. Abionic …See details»
Abionic Company Profile | Management and Employees List
Abionic's cutting-edge Nanotechnology enhances efficiency and versatility of standard ELISA tests to deliver optimal point of care (POC) treatment options with the ability to reduce the …See details»
Abionic 2025 Company Profile: Valuation, Funding
Abionic General Information Description. Developer of a nanotechnology-based revolutionary biomedical diagnostic platform designed to improve medical diagnosis. The company's nanofluidic technology-based diagnostic platform …See details»
Abionic SA - Swiss Biotech
Abionic has developed a revolutionary nanofluidic technology providing professionals a unique and ultra-fast point of care diagnostic tool allowing immediate access to results for a large …See details»
Abionic - Funding, Financials, Valuation & Investors - Crunchbase
Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How …See details»
Abionic | IT History Society
Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection. Abionic SA is a certified ISO 9001/13485 company, including …See details»
Abionic SA - startup.ch
Abionic is a dynamic scale up company based in Switzerland, which is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from …See details»
Abionic - Org Chart, Teams, Culture & Jobs - The Org
View Abionic's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Abionic - Contacts, Employees, Board Members, Advisors & Alumni
Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. New. Resources. ... Experience the new Crunchbase, powered by AI . …See details»
Abionic Company Profile - Office Locations, Competitors ... - Craft
Abionic has 5 employees at their 1 location and $27.44 m in total funding,. See insights on Abionic including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Abionic - Research and Development - The Org
The Research and Development team at Abionic focuses on pioneering innovative solutions at the intersection of medical technology, biotechnology, and nanotechnology. Comprising experts in …See details»
Abionic: Vision, Key Products and Strategic Direction
Where can Abionic’s rapid testing solutions play a role in optimised workflow management? Optimising hospital workflows is the key to unlocking operational efficiencies and financial …See details»
Abionic SA - Venturelab
Abionic is a dynamic scale up company based in Switzerland, which is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from …See details»
Abionic Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Abionic. See Abionic company profile and funding data.See details»
Sepsis Alliance Institute: Abionic: Sepsis Advocate
2023, Abionic is a Swiss MedTech company spun-out of EPFL in 2010 on a vision nanofluidics could transform diagnostics. Our flagship abioSCOPE®, a near-patient rapid diagnostic …See details»
Abionic Receives IVDR Certification for Its Predictive Ultra-Rapid ...
Aug 9, 2022 About Abionic Founded in 2010, Abionic is a Swiss Medtech company commercializing a revolutionary nanofluidic technology, providing healthcare professionals …See details»
Abionic SA - HealthManagement.org
FDA Clears Abionic’s IVD CAPSULE PSP for the Early Detection of Sepsis. 2024 02 Oct Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, …See details»